Threshold Pharma (THLD) Misses Q3 EPS by 3c

November 3, 2014 7:07 AM EST

Threshold Pharma (NASDAQ: THLD) reported Q3 EPS of ($0.15), $0.03 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $3.7 million versus the consensus estimate of $3.82 million.

For earnings history and earnings-related data on Threshold Pharma (THLD) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings